Top 6 Companies Advancing Diabetes Care and Dominating the Global Blood Glucose Meters Market

B. Braun Melsungen AG, Medtronic plc, Abbott Laboratories, Dexcom, Inc., Terumo Europe NV, and F Hoffmann-La Roche Ltd, among others, are the major players in the global blood glucose meters market.

The global blood glucose meters market is expected to grow at a CAGR of about 8.6% in the forecast period of 2022-2027. As per the analysis by Expert Market Research, the market is expected to be driven by the growing cases of diabetes across the globe.

With the growing number of diabetic patients globally and the rising concerns regarding diabetes as a health crisis, the demand for blood glucose meters is surging. The increasing focus on diabetes management through self-monitoring of blood glucose (SMBG) is boosting the sales of blood glucose meters owing to their ease of usage and enhanced accessibility. In addition, the demand for blood glucose meters offering cost-effectiveness and consistency is significantly growing. The rising demand for meters that can rapidly read glucose levels is further favouring the market growth.

Various governments are extensively spending to advance healthcare in both developed and developing countries, which is propelling the market growth of blood glucose meters. Further, the growing popularity of connected blood glucose meters that can be linked with smartphones for providing digitally logged blood glucose patterns to consumers is augmenting the market growth. Technological advancements and innovations are surging the reliability and accuracy of blood glucose meters, which is expected to drive their demand. Moreover, the development of non-invasive blood glucose meters that determine blood glucose concentration without finger pricks is likely to aid the market in the forecast period.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Top 6 Blood Glucose Meters Companies in the World:

B. Braun Melsungen AG

B. Braun Melsungen AG is a healthcare solutions company. It has an extensive portfolio of over 5,000 product ranges and production facilities in more than 64 countries across the globe. With above 300 subsidiaries, the company has an employee base of 66,000. In May 2022, Aesculap, the company’s surgery division, secured exclusive distribution and long-term rights for the jointly developed Aesculap Aeos® digital surgical microscope.

Medtronic plc

Medtronic plc is a prominent medical device company that is engaged in the treatment of chronic health issues. With an employee base of 90,000 across 150 countries across the globe, the company treats over 70 health conditions such as Parkinson’s and diabetes. In 2021, it invested USD 2.5 billion in research and development activities and conducted 370 clinical trials. It has 49,000 patents and the company’s solutions have served over 72 million patients across the globe.

Abbott Laboratories

Abbott Laboratories is a medical devices company, based in the United States. Its products are used in diagnostics, diabetes, cardiovascular, pharmaceuticals, and neuromodulation solutions. With an extensive presence in over 160 countries, the company boasts an employee base of 113,000. The company aims to develop innovative technologies for supporting people to lead quality and healthy lives.

Dexcom, Inc.

Dexcom, Inc. is a medical devices company that is engaged in the development and manufacturing of continuous glucose monitoring systems. The company aims to improve and simplify diabetes management across the world. In August 2022, the company, along with NHS, announced the availability of the Dexcom ONE rt-CGM System on prescription in the United Kingdom.

Terumo Europe NV

Terumo Europe NV is a leading healthcare company in the EMEA market. It aims to provide the best-in-quality products in diabetes, cardiology, oncology, and infusion therapy. It has 70 ongoing and complete clinical trials, and more than 80,000 patients are enrolled in its clinical trials. In August 2022, the company’s and Kyowa Kirin’s co-developed "G-Lasta® Subcutaneous Injection 3.6 mg BodyPod" received approval from the Japanese Ministry of Health, Labour, and Welfare.

F Hoffmann-La Roche Ltd

F. Hoffmann-La Roche AG is a prominent biotech and healthcare company that is involved in the development of innovative medicines, treatments, and diagnostics. Its major divisions, namely Roche Pharma and Roche Diagnostics, focus on achieving medical breakthroughs. Its medicines are used to treat over 28 million people. Moreover, it has a vast presence in over 95 countries.
 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.